WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006124695) 3, 7 OR 3 AND 7 THIA OR OXA PROSTANOIC ACID DERIVATIVES COMBINED WITH ANOTHER DRUG FOR LOWERING INTRAOCULAR PRESSURE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/124695    International Application No.:    PCT/US2006/018585
Publication Date: 23.11.2006 International Filing Date: 15.05.2006
IPC:
A61K 31/5575 (2006.01), A61K 31/559 (2006.01), A61P 27/06 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive, Irvine, CA 92612 (US) (For All Designated States Except US).
BURK, Robert, M. [US/US]; (US) (For US Only).
HOLOBOSKI, Mark [US/US]; (US) (For US Only).
WHITCUP, Scott, M. [US/US]; (US) (For US Only).
IM, Wha-bin [US/US]; (US) (For US Only)
Inventors: BURK, Robert, M.; (US).
HOLOBOSKI, Mark; (US).
WHITCUP, Scott, M.; (US).
IM, Wha-bin; (US)
Agent: JOHNSON, Brent, A.; ALLERGAN, INC., 2525 Dupont Drive, Irvine, CA 92612 (US)
Priority Data:
11/130,863 16.05.2005 US
09/882,720 14.06.2001 US (Considered void 16.08.2006)
10/346,828 16.01.2003 US (Considered void 16.08.2006)
10/672,499 26.09.2003 US (Considered void 16.08.2006)
Title (EN) 3, 7 OR 3 AND 7 THIA OR OXA PROSTANOIC ACID DERIVATIVES COMBINED WITH ANOTHER DRUG FOR LOWERING INTRAOCULAR PRESSURE
(FR) POLYTHERAPIE POUR LE TRAITEMENT DU GLAUCOME
Abstract: front page image
(EN)A method is disclosed herein comprising administering a compound and a second drug to an eye of a mammal for the treatment of glaucoma or the reduction of intraocular pressure, said compound represented by the general formula I; wherein A, B, D, X, Y, Z, R1, R3 and R4 are as defined in the specification.
(FR)L'invention concerne une méthode consistant à administrer un composé et un second médicament dans un oeil d'un mammifère pour le traitement d'un glaucome ou la réduction d'une tension intraoculaire, ledit composé étant représenté par la formule générale I, dans laquelle A, B, D, X, Y, Z, R1, R3 et R4 sont tels que définis dans la description.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)